Exagen (XGN) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Exagen (XGN) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 2.45% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.12% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -53.05% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 3.64% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.08% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 78.37% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 49.22% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -1.69% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -16.05% |
| 10 | Exagen | 156.59 Mn | 131.99 Mn | 12.22 Mn | 59.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.52% |
| Mar 31, 2026 | 55.33% |
| Dec 31, 2025 | 213.79% |
| Sep 30, 2025 | 58.52% |
| Jun 30, 2025 | 48.43% |
| Mar 31, 2025 | -69.59% |
| Dec 31, 2024 | 28.02% |
| Sep 30, 2024 | 4.72% |
| Jun 30, 2024 | 18.90% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | -44.72% |
| Sep 30, 2023 | -96.03% |
| Jun 30, 2023 | -144.32% |
| Mar 31, 2023 | -178.37% |
| Dec 31, 2022 | 234.19% |
| Sep 30, 2022 | -300.96% |
| Jun 30, 2022 | -26.70% |
| Mar 31, 2022 | 15.25% |
| Dec 31, 2021 | -291.23% |
| Sep 30, 2021 | -81.31% |